Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


13 Ann Intern Med
2 Drug Saf
1 J Gen Virol
1 J Immunol
2 J Infect Dis
4 J Virol
6 Lancet
3 MMWR Morb Mortal Wkly Rep
7 N Engl J Med
1 PLoS Biol
5 PLoS Comput Biol
4 PLoS Med
45 PLoS One
4 Proc Natl Acad Sci U S A
1 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. DIONNE JC, Oczkowski SJW
    In patients hospitalized with COVID-19, adding convalescent plasma to usual care did not reduce 28-d mortality.
    Ann Intern Med. 2021 Oct 5. doi: 10.7326/ACPJ202110190.
    PubMed         Abstract available

  2. MATHENY M, Maleque N, Channell N, Eisch AR, et al
    Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/L21-0250.

  3. BUTT AA, Omer SB, Yan P, Shaikh OS, et al
    SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-1577.
    PubMed         Abstract available

  4. ESTELLE CD, Perl TM
    To Test or Not to Test: COVID-19 Prevention Strategies to Keep Large Gatherings Safe.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-2976.

  5. LLIBRE JM, Videla S, Clotet B, Revollo B, et al
    Screening for SARS-CoV-2 Antigen Before a Live Indoor Music Concert: An Observational Study.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-2278.

  6. CLIFT AK, Saatci D, Coupland CAC, Dambha-Miller H, et al
    Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-1375.

  7. BRETTHAUER M, Helsingen LM, Loberg M, Kalager M, et al
    Evidence and Precaution for Legal Health Interventions: Learning From the COVID-19 Pandemic.
    Ann Intern Med. 2021 Aug 10. doi: 10.7326/M21-2839.

  8. GARG S, Patel K, Pham H, Whitaker M, et al
    Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study.
    Ann Intern Med. 2021 Aug 10. doi: 10.7326/M21-1991.
    PubMed         Abstract available

  9. FISMAN DN, Greer AL, Brankston G, Hillmer M, et al
    COVID-19 Case Age Distribution: Correction for Differential Testing by Age.
    Ann Intern Med. 2021 Aug 17. doi: 10.7326/M20-7003.
    PubMed         Abstract available

  10. MEHTA HB, An H, Andersen KM, Mansour O, et al
    Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.
    Ann Intern Med. 2021 Aug 17. doi: 10.7326/M21-0857.
    PubMed         Abstract available

    The Race to Understand Post-COVID-19 Conditions.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-3072.

  12. TONG SYC, Petersiel N
    Tofacitinib reduced death or respiratory failure at 28 d in patients hospitalized with COVID-19 pneumonia.
    Ann Intern Med. 2021 Oct 5. doi: 10.7326/ACPJ202110190.
    PubMed         Abstract available

  13. DIEP R, Garcia D
    In COVID-19, therapeutic vs. prophylactic anticoagulation did not improve clinical outcomes and increased bleeding.
    Ann Intern Med. 2021 Oct 5. doi: 10.7326/ACPJ202110190.
    PubMed         Abstract available


  14. VENTURA D, Aith F, Reis R
    Crimes against humanity in Brazil's covid-19 response-a lesson to us all.
    BMJ. 2021;375:n2625.

  15. SIDEBOTTOM DB, Smith DD, Gill D
    Safety and efficacy of antivirals against SARS-CoV-2.
    BMJ. 2021;375:n2611.

  16. ALWAN NA
    We must call out childism in covid-19 policies.
    BMJ. 2021;375:n2641.

    Getting molnupiravir to patients in a timely way is likely to be problematic.
    BMJ. 2021;375:n2648.

    Drug Saf

  18. CLINTON JW, Kiparizoska S, Aggarwal S, Woo S, et al
    Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature.
    Drug Saf. 2021;44:1125-1149.
    PubMed         Abstract available

  19. IGUCHI T, Umeda H, Kojima M, Kanno Y, et al
    Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report.
    Drug Saf. 2021;44:1209-1214.
    PubMed         Abstract available

    J Gen Virol

  20. SEALY JE, Howard WA, Molesti E, Iqbal M, et al
    Amino acid substitutions in the H5N1 avian influenza haemagglutinin alter pH of fusion and receptor binding to promote a highly pathogenic phenotype in chickens.
    J Gen Virol. 2021;102.
    PubMed         Abstract available

    J Immunol

  21. GAJANAYAKA N, Dong SXM, Ali H, Iqbal S, et al
    TLR-4 Agonist Induces IFN-gamma Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K Pathway.
    J Immunol. 2021;207:2310-2324.
    PubMed         Abstract available

    J Infect Dis

  22. HUKIC M, Avdihodzic H, Veledar E, Korkut E, et al
    Potential Effect of Previous Human Coronavirus NL63 Infection on the Rate of Infection and the Clinical Course of Coronavirus Disease 2019.
    J Infect Dis. 2021;224:1444-1445.

  23. STOSOR V, Angarone MP
    Not All Monoclonal Antibodies for Coronavirus Disease 2019 Are Created Equal.
    J Infect Dis. 2021;224:1275-1277.

    J Virol

  24. XUN G, Song X, Hu J, Zhang H, et al
    Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
    J Virol. 2021;95:e0048521.
    PubMed         Abstract available

  25. KREUTZBERGER AJB, Sanyal A, Ojha R, Pyle JD, et al
    Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
    J Virol. 2021 Aug 18:JVI0097521. doi: 10.1128/JVI.00975.
    PubMed         Abstract available

  26. CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
    A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
    J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
    PubMed         Abstract available

  27. DONG X, Wang X, Xie M, Wu W, et al
    Structural Basis of Human Parainfluenza Virus 3 Unassembled Nucleoprotein in Complex with Its Viral ChaperoneHPIV3 Nucleoprotein-Phosphoprotein Structure.
    J Virol. 2021 Nov 3:JVI0164821. doi: 10.1128/JVI.01648.
    PubMed         Abstract available


    Antithrombotic Therapy for Outpatients With COVID-19: Implications for Clinical Practice and Future Research.
    JAMA. 2021 Oct 11. pii: 2785220. doi: 10.1001/jama.2021.17460.

  29. DALLE AVE AL, Sulmasy DP
    Health Care Professionals' Spirituality and COVID-19: Meaning, Compassion, Relationship.
    JAMA. 2021 Oct 8. pii: 2785147. doi: 10.1001/jama.2021.16769.

  30. ABBASI J
    COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes.
    JAMA. 2021 Oct 6. pii: 2784943. doi: 10.1001/jama.2021.13326.


    An opportunity for American renewal.
    Lancet. 2021;397:171.

    A sporting chance: physical activity as part of everyday life.
    Lancet. 2021;398:365.

    A time of crisis for the opioid epidemic in the USA.
    Lancet. 2021;398:277.

  34. PINTO FJ, Pineiro D, Banerjee A, Perel P, et al
    World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease.
    Lancet. 2021 Sep 28. pii: S0140-6736(21)02144.

  35. TARTOF SY, Slezak JM, Fischer H, Hong V, et al
    Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02183.
    PubMed         Abstract available

  36. XUE W, White A
    COVID-19 and the rebiologisation of racial difference.
    Lancet. 2021;398:1479-1480.

    MMWR Morb Mortal Wkly Rep

  37. MBAEYI S, Oliver SE, Collins JP, Godfrey M, et al
    The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1545-1552.
    PubMed         Abstract available

  38. BOZIO CH, Grannis SJ, Naleway AL, Ong TC, et al
    Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1539-1544.
    PubMed         Abstract available

  39. EMBI PJ, Levy ME, Naleway AL, Patel P, et al
    Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1553-1559.
    PubMed         Abstract available

    N Engl J Med

  40. STEUWER B, Eyal N
    SARS-CoV-2 Human Challenge Studies.
    N Engl J Med. 2021 Sep 29. pii: 10.1056/NEJMc2113574.

  41. RAPEPORT G, Chiu C, McShane H
    SARS-CoV-2 Human Challenge Studies. Reply.
    N Engl J Med. 2021 Sep 29. pii: 10.1056/NEJMc2113574.

  42. SANTACATTERINA M, Sanders JW, Weintraub WS
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.

    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.

  44. ZHANG C, Yin G
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.

  45. THOMPSON MG, Grant L, Meece J
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. Reply.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.

  46. MONTO AS
    The Future of SARS-CoV-2 Vaccination - Lessons from Influenza.
    N Engl J Med. 2021 Nov 6. doi: 10.1056/NEJMp2113403.

    PLoS Biol

    Wildlife must be protected from crime and trade for the sake of public and planetary health.
    PLoS Biol. 2021;19:e3001422.
    PubMed         Abstract available

    PLoS Comput Biol

  48. GUIGNON V, Breton C, Mariette J, Sabot F, et al
    Ten simple rules for switching from face-to-face to remote conference: An opportunity to estimate the reduction in GHG emissions.
    PLoS Comput Biol. 2021;17:e1009321.
    PubMed         Abstract available

  49. COTMAN ZJ, Bowden MJ, Richter BP, Phelps JH, et al
    Factors affecting aerosol SARS-CoV-2 transmission via HVAC systems; a modeling study.
    PLoS Comput Biol. 2021;17:e1009474.
    PubMed         Abstract available

  50. CHEN D, Xue Y, Xiao Y
    Determining travel fluxes in epidemic areas.
    PLoS Comput Biol. 2021;17:e1009473.
    PubMed         Abstract available

  51. AYLETT-BULLOCK J, Cuesta-Lazaro C, Quera-Bofarull A, Katta A, et al
    Operational response simulation tool for epidemics within refugee and IDP settlements: A scenario-based case study of the Cox's Bazar settlement.
    PLoS Comput Biol. 2021;17:e1009360.
    PubMed         Abstract available

  52. HOWERTON E, Ferrari MJ, Bjornstad ON, Bogich TL, et al
    Synergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing.
    PLoS Comput Biol. 2021;17:e1009518.
    PubMed         Abstract available

    PLoS Med

  53. POLLETT S, Johansson MA, Reich NG, Brett-Major D, et al
    Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines.
    PLoS Med. 2021;18:e1003793.
    PubMed         Abstract available

  54. GENG EH, Reid MJA, Goosby E, Abdool-Karim Q, et al
    COVID-19 and global equity for health: The good, the bad, and the wicked.
    PLoS Med. 2021;18:e1003797.
    PubMed         Abstract available

  55. PEARSON CAB, Bozzani F, Procter SR, Davies NG, et al
    COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    PLoS Med. 2021;18:e1003815.
    PubMed         Abstract available

  56. IOANNOU GN, Ferguson JM, O'Hare AM, Bohnert ASB, et al
    Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.
    PLoS Med. 2021;18:e1003807.
    PubMed         Abstract available

    PLoS One

  57. HOROWITZ MC, Kahn L
    What influences attitudes about artificial intelligence adoption: Evidence from U.S. local officials.
    PLoS One. 2021;16:e0257732.
    PubMed         Abstract available

  58. SQUAZZONI F, Bravo G, Grimaldo F, Garcia-Costa D, et al
    Gender gap in journal submissions and peer review during the first wave of the COVID-19 pandemic. A study on 2329 Elsevier journals.
    PLoS One. 2021;16:e0257919.
    PubMed         Abstract available

  59. ADAMS-CLARK AA, Freyd JJ
    COVID-19-related institutional betrayal associated with trauma symptoms among undergraduate students.
    PLoS One. 2021;16:e0258294.
    PubMed         Abstract available

  60. ABEYA SG, Barkesa SB, Sadi CG, Gemeda DD, et al
    Adherence to COVID-19 preventive measures and associated factors in Oromia regional state of Ethiopia.
    PLoS One. 2021;16:e0257373.
    PubMed         Abstract available

  61. STROEBE W, vanDellen MR, Abakoumkin G, Lemay EP Jr, et al
    Politicization of COVID-19 health-protective behaviors in the United States: Longitudinal and cross-national evidence.
    PLoS One. 2021;16:e0256740.
    PubMed         Abstract available

  62. NGUYEN BT, Pang RD, Nelson AL, Pearson JT, et al
    Detecting variations in ovulation and menstruation during the COVID-19 pandemic, using real-world mobile app data.
    PLoS One. 2021;16:e0258314.
    PubMed         Abstract available

  63. HENNESSY S, Sachs M, Kaplan J, Habibi A, et al
    Music and mood regulation during the early stages of the COVID-19 pandemic.
    PLoS One. 2021;16:e0258027.
    PubMed         Abstract available

  64. CREMER S, Pilgram L, Berkowitsch A, Stecher M, et al
    Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease.
    PLoS One. 2021;16:e0258684.
    PubMed         Abstract available

  65. VIVES-CASES C, La Parra-Casado D, Briones-Vozmediano E, March S, et al
    Coping with intimate partner violence and the COVID-19 lockdown: The perspectives of service professionals in Spain.
    PLoS One. 2021;16:e0258865.
    PubMed         Abstract available

  66. CHERTOK D, Konchak C, Shah N, Singh K, et al
    An operationally implementable model for predicting the effects of an infectious disease on a comprehensive regional healthcare system.
    PLoS One. 2021;16:e0258710.
    PubMed         Abstract available

  67. KERZIC D, Alex JK, Pamela Balbontin Alvarado R, Bezerra DDS, et al
    Academic student satisfaction and perceived performance in the e-learning environment during the COVID-19 pandemic: Evidence across ten countries.
    PLoS One. 2021;16:e0258807.
    PubMed         Abstract available

  68. WARD T, Johnsen A
    Understanding an evolving pandemic: An analysis of the clinical time delay distributions of COVID-19 in the United Kingdom.
    PLoS One. 2021;16:e0257978.
    PubMed         Abstract available

  69. ILOSKICS Z, Sebestyen T, Braun E
    Shock propagation channels behind the global economic contagion network. The role of economic sectors and the direction of trade.
    PLoS One. 2021;16:e0258309.
    PubMed         Abstract available

  70. KUBOTA J, Hirano D, Okabe S, Yamauchi K, et al
    Utility of the Global Respiratory Severity Score for predicting the need for respiratory support in infants with respiratory syncytial virus infection.
    PLoS One. 2021;16:e0253532.
    PubMed         Abstract available

  71. SALERNO D, Oriaku I, Darnell M, Lanclus M, et al
    Association of abnormal pulmonary vasculature on CT scan for COVID-19 infection with decreased diffusion capacity in follow up: A retrospective cohort study.
    PLoS One. 2021;16:e0257892.
    PubMed         Abstract available

  72. GRONDAL M, Ask K, Luke TJ, Winblad S, et al
    Self-reported impact of the COVID-19 pandemic, affective responding, and subjective well-being: A Swedish survey.
    PLoS One. 2021;16:e0258778.
    PubMed         Abstract available

  73. ALISHAQ M, Nafady-Hego H, Jeremijenko A, Al Ajmi JA, et al
    Risk factors for breakthrough SARS-CoV-2 infection in vaccinated healthcare workers.
    PLoS One. 2021;16:e0258820.
    PubMed         Abstract available

  74. AHMED DA, Ansari AR, Imran M, Dingle K, et al
    Mechanistic modelling of COVID-19 and the impact of lockdowns on a short-time scale.
    PLoS One. 2021;16:e0258084.
    PubMed         Abstract available

  75. KIPTANUI Z, Ghosh S, Ali S, Desai K, et al
    Transparency, health equity, and strategies in state-based protocols for remdesivir allocation and use.
    PLoS One. 2021;16:e0257648.
    PubMed         Abstract available

  76. FAVERIO P, Ornaghi S, Stainer A, Invernizzi F, et al
    Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre.
    PLoS One. 2021;16:e0258754.
    PubMed         Abstract available

  77. ANDRASIK MP, Broder GB, Wallace SE, Chaturvedi R, et al
    Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
    PLoS One. 2021;16:e0258858.
    PubMed         Abstract available

  78. PILCH I, Wardawy P, Probierz E
    The predictors of adaptive and maladaptive coping behavior during the COVID-19 pandemic: The Protection Motivation Theory and the Big Five personality traits.
    PLoS One. 2021;16:e0258606.
    PubMed         Abstract available

  79. STANLEY B, Davis A, Jones R, Julious S, et al
    Characteristics of patients in platform C19, a COVID-19 research database combining primary care electronic health record and patient reported information.
    PLoS One. 2021;16:e0258689.
    PubMed         Abstract available

  80. JEZIERSKI T, Camerlink I, Peden RSE, Chou JY, et al
    Cat owners' perception on having a pet cat during the COVID-19 pandemic.
    PLoS One. 2021;16:e0257671.
    PubMed         Abstract available

  81. BAGI HM, Soleimanpour M, Abdollahi F, Soleimanpour H, et al
    Evaluation of clinical outcomes of patients with mild symptoms of coronavirus disease 2019 (COVID-19) discharged from the emergency department.
    PLoS One. 2021;16:e0258697.
    PubMed         Abstract available

  82. XU Z, Zhang D, Xu D, Li X, et al
    Loneliness, depression, anxiety, and post-traumatic stress disorder among Chinese adults during COVID-19: A cross-sectional online survey.
    PLoS One. 2021;16:e0259012.
    PubMed         Abstract available

  83. KAMBAYASHI D, Manabe T, Kawade Y, Hirohara M, et al
    Knowledge, attitudes, and practices regarding COVID-19 among pharmacists partnering with community residents: A national survey in Japan.
    PLoS One. 2021;16:e0258805.
    PubMed         Abstract available

  84. HUSSAIN ALSAYED HA, Saheb Sharif-Askari F, Saheb Sharif-Askari N, Hussain AAS, et al
    Early administration of remdesivir to COVID-19 patients associates with higher recovery rate and lower need for ICU admission: A retrospective cohort study.
    PLoS One. 2021;16:e0258643.
    PubMed         Abstract available

    Disparity between knowledge and practice regarding COVID-19 in Thailand: A cross-sectional study of older adults.
    PLoS One. 2021;16:e0259154.
    PubMed         Abstract available

  86. NASCIMENTO DE LIMA P, Lempert R, Vardavas R, Baker L, et al
    Reopening California: Seeking robust, non-dominated COVID-19 exit strategies.
    PLoS One. 2021;16:e0259166.
    PubMed         Abstract available

  87. FRAMPTON G, Woods L, Scott DA
    Inconsistent and incomplete retraction of published research: A cross-sectional study on Covid-19 retractions and recommendations to mitigate risks for research, policy and practice.
    PLoS One. 2021;16:e0258935.
    PubMed         Abstract available

  88. CIBRIAN FL, Monteiro E, Ankrah E, Beltran JA, et al
    Parents' perspectives on a smartwatch intervention for children with ADHD: Rapid deployment and feasibility evaluation of a pilot intervention to support distance learning during COVID-19.
    PLoS One. 2021;16:e0258959.
    PubMed         Abstract available

  89. MILIC M, Dotlic J, Rachor GS, Asmundson GJG, et al
    Validity and reliability of the Serbian COVID Stress Scales.
    PLoS One. 2021;16:e0259062.
    PubMed         Abstract available

  90. LEONHARDT JM, Ridinger G, Rong Y, Talaei-Khoe A, et al
    Invincibility threatens vaccination intentions during a pandemic.
    PLoS One. 2021;16:e0258432.
    PubMed         Abstract available

  91. KIM JY, Jung KJ, Yoo SJ, Yoon SH, et al
    Stratifying the early radiologic trajectory in dyspneic patients with COVID-19 pneumonia.
    PLoS One. 2021;16:e0259010.
    PubMed         Abstract available

  92. ANTONIOU R, Romero-Kornblum H, Young JC, You M, et al
    Reduced utilitarian willingness to violate personal rights during the COVID-19 pandemic.
    PLoS One. 2021;16:e0259110.
    PubMed         Abstract available

  93. BEALL RF, Moradpour J, Hollis A
    The private versus public contribution to the biomedical literature during the COVID-19, Ebola, H1N1, and Zika public health emergencies.
    PLoS One. 2021;16:e0258013.
    PubMed         Abstract available

  94. AL KASSAA I, El Omari S, Abbas N, Papon N, et al
    High association of COVID-19 severity with poor gut health score in Lebanese patients.
    PLoS One. 2021;16:e0258913.
    PubMed         Abstract available

  95. CAPLAN A, Bates KW, Brioni C, Santos A, et al
    Clinical characteristics and viral load dynamics of COVID-19 in a mildly or moderately symptomatic outpatient sample.
    PLoS One. 2021;16:e0258970.
    PubMed         Abstract available

  96. KARAPETYAN S, Schneider A, Linde K, Donnachie E, et al
    SARS-CoV-2 infection and cardiovascular or pulmonary complications in ambulatory care: A risk assessment based on routine data.
    PLoS One. 2021;16:e0258914.
    PubMed         Abstract available

  97. AUSTRIA B, Haque R, Mittal S, Scott J, et al
    Mortality in association with antipsychotic medication use and clinical outcomes among geriatric psychiatry outpatients with COVID-19.
    PLoS One. 2021;16:e0258916.
    PubMed         Abstract available

  98. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0259006.
    PubMed         Abstract available

  99. FAIRS A, Strijkers K
    Can we use the internet to study speech production? Yes we can! Evidence contrasting online versus laboratory naming latencies and errors.
    PLoS One. 2021;16:e0258908.
    PubMed         Abstract available

  100. ISMAIL K, Bensasi H, Taha A, Nazir A, et al
    Characteristics and outcome of critically ill patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to a tertiary care center in the United Arab Emirates during the first wave of the SARS-CoV-2 pandemic. A retrospective analysis.
    PLoS One. 2021;16:e0251687.
    PubMed         Abstract available

  101. TEO I, Chay J, Cheung YB, Sung SC, et al
    Healthcare worker stress, anxiety and burnout during the COVID-19 pandemic in Singapore: A 6-month multi-centre prospective study.
    PLoS One. 2021;16:e0258866.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  102. ZHANG L, Richards A, Barrasa MI, Hughes SH, et al
    Reply to Briggs et al.: Genomic integration and expression of SARS-CoV-2 sequences can explain prolonged or recurrent viral RNA detection.
    Proc Natl Acad Sci U S A. 2021;118.

  103. BRIGGS E, Ward W, Rey S, Law D, et al
    Assessment of potential SARS-CoV-2 virus integration into human genome reveals no significant impact on RT-qPCR COVID-19 testing.
    Proc Natl Acad Sci U S A. 2021;118.

  104. SUN L, Kallolimath S, Palt R, Stiasny K, et al
    Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  105. LEVY R, Zhang P, Bastard P, Dorgham K, et al
    Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  106. NOWALK MP, D'Agostino HEA, Zimmerman RK, Saul SG, et al
    Agreement among sources of adult influenza vaccination in the age of immunization information systems.
    Vaccine. 2021 Oct 26. pii: S0264-410X(21)01372.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.